Print Page   |   Contact Us   |   Sign In   |   Join iBIO
2014 iBIO IndEx Agenda - April 24


7:00 – 8:00 AM


8:00 – 8:15 AM

Morning Keynote

8:15 – 9:00 AM

John J. Castellani, President, Pharmaceutical Research and Manufacturers of America


Panel Session

9:00 – 10:30 AM

Innovative Data Use to Drive Clinical Trial Optimization and Treatment



Patient data is being used in new and innovative ways to optimize clinical trials and treatments. Through integration of patient’s clinical data, tissue, and molecular data, it provides the ability to discover new biomarkers and drug targets, enhanced ability to match patient to right treatment or clinical trials, superior data for clinical decision-making, and improved ability to track and understand patient treatments, outcomes and costs. Deloitte is a leader in helping companies innovate and implement solutions, using data to maximize clinical trial outcomes and patient treatments. This session will review what is happening today and is poised to happen in the future through innovative use of data.



  • Steven Pratt, Principal, Deloitte


  • Songlin Xue, MD, PhD, Executive Vice President, Head of Global Pharmacovigilance, Astellas Pharma Global Development, Inc

  • Dr. Bala Hota, MD MPH, Chief Research Information Officer, Associate Professor, Rush University

  • Sumati Murli, PhD, Director, Clinical Research Operations, University of Chicago Comprehensive Cancer Center

Coffee Break

10:30 – 11:00 AM


11:00 AM – 12:00 PM

AdvaMed CEO’s Unplugged


These industry giants will provide their exclusive insights in an intimate, interactive environment. Speakers will discuss the most crucial issues facing the industry, drawing from personal observations and experiences across their fields. Attendees can expect to gain a deep understanding of the industry’s most pressing challenges and opportunities. Audience questions and dialogues are encouraged.



  • Lester B. Knight. Founding Partner & Co-Chairman, RoundTable Healthcare Partners
  • Andrew Cittadine, President & CEO, Diagnostic Photonics
  • John J. Greisch, President & Chief Executive Officer, Hill-Rom
  • Thomas Kapfer, President & CEO, Beaver-Visitec International


12:00 – 1:30 PM 

International panel "The World is Flat:Illinois' links to global lifesceince clusters and markets"

12:00  – 1:30 PM




  • Michael S. Rosen, Sr. Vice-President, New Business Development, Forest City Science + Technology Group


  • Ken Araki, Vice President, Acting Head of Global Licensing and Business Development, Takeda Pharmaceuticals
  • Steve Rhodes, Co-Chairman and CEO, Trendlines
  • Jeff Malehorn, President & CEO, World Business Chicago
  • Daniel Goff, Deputy Director, Illinois Office of Trade & Investment
  • Claudia Roth, President, Vetter Development Services USA, Inc.



1:30 – 3:00 PM

How the Biotech Boom is Changing Deal Structures 


The JOBS Act and changes in the regulatory environment have led to a number of positive changes for the life sciences community. The trend of initial public offerings has led to a recent biotech boom and renewed faith in investors. With the increased number of companies hitting the public market and continued pipeline issues for the existing large companies, how is this driving changes in the deal structure? This panel will review the recent biotech boom and take a forward look at how this trend will continue. It will review how a shifting regulatory environment with the FDA is helping to fuel the trend and how the large companies are going to benefit.


  • John Babitt, Partner, Transaction Advisory Services, Ernst & Young


  • Mike Broxson, Senior Director, Business Development, Takeda
  • James M. Hussey, President, Sagent Pharmaceuticals
  • Mark Tatro, Chief Financial Officer, Crealta Pharmaceuticals


afternoon BREAK

3:00 – 3:30 PM


closing keynote

3:30 – 4:30 PM
Chicago’s Life Sciences Startup Ecosystem 


This panel will provide their insights in an intimate, interactive environment. Speakers will discuss the challenges facing the startup industry in Illinois, drawing from personal observations and experiences. Attendees can expect to gain a deep understanding of the industry’s most pressing challenges and opportunities. Audience questions and dialogues are encouraged.


  • John Pletz, Technology Reporter, Crain's Chicago Business
  • Timothy P. Walbert, Chairman, President & CEO, Horzon Pharma
  • Michael Liang Ph.D., Partner, Baird Venture Partners
  • Dr. Norbert G. Riedel, President & CEO, Naurex, Inc.
  • Adam Pollet, Director, Illinois Department of Commerce and Economic Opportunity
  • Nancy Sullivan, CEO & Managing Director, IllinoisVENTURES, LLC

CLOSING reception

4:30 PM



Association Management Software Powered by YourMembership  ::  Legal